<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"thyroid cyst":1,
"ultrasound-guided percutaneous ethanol injection":1,
"volume reduction rate":1,
"lymph node metastasis":1,
"neck dissection":1,
"papillary thyroid cancer":6,
"thyroid gland":3,
"thyroidectomy":1,
"BRAF":2,
"molecular marker":1,
"papillary thyroid carcinoma":12,
"adenoid cystic pattern":1,
"fine-needle aspiration":3,
"hyaline globule":1,
"spindle-cell thymoma":1,
"type A thymoma":1,
"Hyalinizing trabecular tumor":2,
"core-needle biopsy":1,
"thyroid":5,
"ultrasonography":2,
"CT":2,
"lymph node":1,
"metastasis":7,
"ultrasound":2,
"coexistence":1,
"diffuse large B-cell lymphoma":1,
"primary thyroid lymphoma":1,
"therapy":1,
"hyalinizing trabecular adenoma":1,
"medullary thyroid carcinoma":3,
"fine-needle aspiration cytology":1,
"flow cytometry":1,
"thyroid lymphomas":1,
"Obesity":1,
"Prognosis":3,
"Thyroid neoplasms":6,
"Lateral neck recurrence":1,
"follow-up":1,
"FDG PET/CT":1,
"peritoneal strumosis":1,
"radioiodine scan":1,
"struma ovarii":1,
"Thyroid cancer":17,
"complications of thyroid surgery":1,
"intraoperative neuromonitoring":1,
"patient outcomes":1,
"recurrent laryngeal nerve injury":1,
"cancer":4,
"hyperemesis":1,
"nested case-control":1,
"registry-based":1,
"Circulating tumor cells":1,
"Diagnosis":3,
"Metastasis breast cancer":1,
"Specificity":1,
"miR-21":1,
"height":1,
"meta-analysis":3,
"BRAF V600E":1,
"Colorectal carcinoma":1,
"Immunohistochemistry":3,
"Melanoma":1,
"Thyroid carcinoma":2,
"C8orf4":1,
"Chibby":1,
"Cyclin D1":1,
"Oral cancer":1,
"Thyroid cancer 1":1,
"β-Catenin":1,
"Function prediction":1,
"Prognostic risk gene":1,
"Prognostic risk microRNA":1,
"Target gene":1,
"Thyroid papillary carcinoma":2,
"Calprotectin":1,
"Oxidative stress":1,
"Cell biology":1,
"Microgravity":1,
"Profilin-1":1,
"Random Positioning Machine":1,
"Spaceflight":1,
"Thyroid cancer cells":1,
"Surveillance, Epidemiology, and End Results (SEER)":1,
"gastrointestinal stromal tumor (GIST)":1,
"multiple primary neoplasm":1,
"second primary neoplasms":1,
"synchronous neoplasms":1,
"Nicotinamide phosphoribosyltransferase":1,
"Nodular goiter":1,
"Reverse transcriptase polymerase chain reaction":1,
"Visfatin":1,
"radioiodine therapy":1,
"telemedicine":1,
"telemonitoring":1,
"Adenocarcinoma":1,
"Biomarkers":1,
"Lung cancer":1,
"IL-27":1,
"Polymorphism":2,
"Risk":2,
"Long noncoding RNA":1,
"Microarray":1,
"lncRNA":1,
"mRNA":1,
"Akt/PI3K":1,
"BDNF":1,
"Caspase-3":1,
"GSK-3β":1,
"Lupeol":1,
"Acoustic radiation force impulse":1,
"Chronic autoimmune thyroiditis":1,
"Fibrosis":1,
"Pathologic structure":1,
"Shear wave":1,
"CD1a":1,
"Dendritic cells":1,
"Disease free survival":1,
"BRAF protein":1,
"human":1,
"immunohistocytochemistry":1,
"RAF265":1,
"RET":1,
"SB590885":1,
"ZSTK474":1,
"medullary thyroid cancer":1,
"Diagnostic accuracy":1,
"Elastography":2,
"Parameter":1,
"Thyroid nodule":4,
"Differentiated thyroid cancer":2,
"Follicular thyroid carcinoma":1,
"Targeted therapy":1,
"Tyrosine kinase inhibitors":1,
"Functional pituitary adenoma":1,
"Histological distribution":1,
"Location":1,
"MRI":2,
"hypothyroidism":1,
"metastatic colorectal cancer":1,
"regorafenib":1,
"thyroid-stimulating hormone":1,
"Bone metastases":1,
"Cementoplasty":1,
"Cryosurgery":1,
"Overall survival":1,
"Thermal ablation":1,
"Akt":1,
"PI3K":1,
"Therapy resistance":1,
"Tumorigenesis":1,
"mTOR":1,
"oral contraceptive":1,
"prospective study":1,
"Apoptosis":1,
"Gastric carcinoma (GC)":1,
"Growth":1,
"MET":1,
"MicroRNAs (miRNA)":1,
"miR-449c":1,
"TTF-1":1,
"genitourinary neoplasms":1,
"neuroendocrine tumor":1,
"small cell carcinoma":1,
"upper urinary tract":1,
"ureter":1,
"ureteral":1,
"antibody-drug conjugate":1,
"drug target":1,
"functional genomic mRNA profiling":1,
"mesothelin":1,
"overexpression":1,
"cancer associated fibroblasts":1,
"epithelial-mesenchymal transition":1,
"hypoxia inducible factor-1α":1,
"prostate cancer":1,
"pyruvate kinase M2":2,
"Accuracy of FNA":1,
"Cytology":1,
"FNAC":1,
"Follicular lesions":1,
"PTC":1,
"Pitfalls of FNA":1,
"BRAF(V600E)":1,
"Fine-needle aspiration biopsy":1,
"Molecular marker testing":1,
"Suspicious for malignancy":1,
"B-Raf proto-oncogene inhibition":1,
"CD4":1,
"CD8":1,
"melanocytic nevi":1,
"phosphorylated extracellular signal-regulated kinase":1,
"phosphorylated protein kinase B":1,
"Cytogenomic microarray":1,
"Dedifferentiated chondrosarcoma":1,
"Epithelial glandular differentiation":1,
"Mesenchymal epithelial transition":1,
"Next generation sequencing":1,
"CARMA1":1,
"Invasion":1,
"MicroRNA-539":1,
"Migration":1,
"Adolescent":1,
"Outcomes":1,
"Survival":2,
"TYA":1,
"Teenage":1,
"Trends":1,
"UK":1,
"Anaplastic thyroid carcinoma":1,
"CDKN1A":1,
"miR-4295":1,
"Breast cancer":3,
"China":1,
"Disparities":1,
"Body weight":1,
"Thyroid hormones":1,
"Thyrotropin":1,
"Breast neoplasms":1,
"Imaging":1,
"Surgical":1,
"Complication":1,
"Lymphadenectomy":1,
"Surgery":2,
"metachronous":1,
"multiple primary neoplasms":1,
"synchronous":1,
"Differential diagnosis":2,
"focal lymphocytic thyroiditis":1,
"TSH receptor autoantibody":1,
"Total thyroidectomy":1,
"thyroid benign mass":1,
"thyroid-associated orbitopathy":1,
"Doppler sonography":1,
"ectopic thymus":1,
"head and neck ultrasound":1,
"intrathyroidal":1,
"sonography":1,
"Carcinoma papilar":1,
"Epidemiologia":1,
"Epidemiology":2,
"Incidence":1,
"Incidência":1,
"Neoplasias da glândula tireoide":1,
"Nódulo da glândula tireoide":1,
"Papillary carcinoma":1,
"Differentiated thyroid carcinoma":2,
"Quantification":1,
"Radioiodine whole-body scan":1,
"Treatment response":1,
"FDG":1,
"PET":1,
"Schmorl’s node":1,
"Thyroglobulin":2,
"NCOA1":1,
"VEGFa":1,
"transcriptional regulation":1,
"gray-scale ultrasound":1,
"texture analysis":1,
"incidentaloma":1,
"pediatric patients":1,
"reactive oxygen species (ROS)":1,
"signaling pathways":1,
"sulforaphane (SFN)":1,
"C1orf24":1,
"FAM129A":1,
"NIBAN":1,
"follicular thyroid carcinoma and papillary thyroid carcinoma":1,
"miR-106b":1,
"computational model":1,
"Extracapsular Spread":1,
"Metastatic Lymph Node":1,
"Thyroid Cancer, Papillary":1,
"chemotherapy":1,
"chitosan":1,
"cupreous complexes":1,
"nanocomposites":1,
"photothermal therapy":1,
"Cdx2":1,
"Foxa2":1,
"Nkx2-1":1,
"genetically engineered mouse model of cancer":1,
"lung adenocarcinoma":1,
"TKIs":1,
"sorafenib":1,
"sunitinib":1,
"vandetanib":1,
"metabolic syndrome":1,
"prevalence":1,
"risk factor":1,
"clinical features":1,
"orbital metastasis":1,
"orbital tumors":1,
"Asia":1,
"Mutation":1,
"Oncogene proteins ras":1,
"PPAR gamma":1,
"Proto-oncogene proteins B-raf":1,
"Ret-PTC fusion oncoproteins":1,
"Telomerase":1,
"Secondary hypertension":1,
"echocardiography":1,
"multiple endocrine neoplasia":1,
"pheochromocytoma":1,
"Chernobyl":1,
"Fukushima":1,
"Papillary microcarcinoma":1,
"Thyroid cancer pathogenesis":1,
"Thyroid growth":1,
"FOXO1":1,
"K1":1,
"TPC1 cells":1,
"miR-96":1,
"AMPK/mTOR":1,
"autophagy":1,
"transmembrane protein 21":1,
"MSH3":1,
"Insular thyroid cancer":1,
"multifocality":1,
"poorly differentiated thyroid cancer":1,
"vascular invasion":1,
"CXCR1":1,
"EGFR":1,
"GPER1":1,
"follicular thyroid adenoma (FTA)":1,
"follicular thyroid carcinoma (FTC)":1,
"cervical dissection":1,
"lymph node metastases":1,
"quantitative analysis":1,
"Ectopic hamartomatous thymoma":1,
"neck":1,
"thymoma":1,
"tumor":2,
"elasticity imaging":1,
"microbubble":1,
"SHP2":1,
"expression":1,
"tumour proliferation":1,
"carcinoma":1,
"differentiated":1,
"papillary":1,
"undifferentiated":1,
"BRAF (V600E) mutation":1,
"clinicopathologic features":1,
"p53 protein":1,
"Body mass index":1,
"thyroid papillary microcarcinoma":1,
"Cervical lymph node":1,
"Fine needle aspiration cytology":1,
"Adrenal mass":1,
"Oligometastasis":1,
"Renal tumor":1,
"Biopsy":1,
"Breast":1,
"Lateral decubitus position":1,
"Microcalcification":1,
"Stereotactic techniques":1,
"BRAF inhibitor":1,
"BRAF mutation":1,
"vemurafenib":1,
"Glycolysis":1,
"Phosphorylation":1,
"Xenograft":1,
"Choroid":1,
"Lung carcinoma":1,
"Orbit":1,
"Choroidal hemangioma":1,
"Choroidal metastasis":1,
"Neuroendocrine carcinoma":1,
"Small-cell carcinoma":1,
"Bone metastasis":1,
"Clavicle metastasis":1,
"Teratoma":1,
"Adrenocortical carcinoma":1,
"Endocrine cancer":1,
"Metastatic adrenal carcinoma":1,
"Retroperitoneal hemorrhage":1,
"Spontaneous rupture":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年9月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
